[Cancer Research Institute](https://www.cancerresearch.org)

November 2025 (Letter of Intent) | March 2026 (Full Application)

Up to $150,000/year for 2 years (max $300,000 total); no indirect costs allowed.

Supports innovative technology development to accelerate cancer immunotherapy research and its translation to clinical application.

Faculty appointment (assistant professor or higher) required by award activation.

--- ## Description The Cancer Research Institute Technology Impact Award provides seed funding for the development and validation of novel platform technologies with the potential to transform cancer immunotherapy research. The program aims to bridge the gap between technology innovation and clinical application, encouraging collaboration between technology developers and clinical cancer immunologists. Supported projects may include new bioinformatics approaches, in silico modeling, tumor profiling instrumentation, innovative assays, or other technologies that offer new insights into the mechanisms of cancer immunotherapy. The award prioritizes proposals that are creative, technically sophisticated, and have high potential for global impact on immunotherapy development. --- ## Due Dates - **Letter of Intent (anticipated):** November 2025 - **Notification of invitation to submit full application (anticipated):** February 2026 - **Full Application (anticipated):** March 2026 - **Earliest award activation (anticipated):** July 2026 *All dates are projected based on the annual cycle; check the program page for updates.* --- ## Funding Amount - Up to $150,000 per year for two years (maximum $300,000 total) - No indirect costs allowed; funds may be used for salary, technical assistance, supplies, capital equipment, or scientific travel - Payments are made quarterly to the host institution --- ## Eligibility - Applicants must hold a faculty appointment as a tenure-track assistant professor (or higher) at the time of award activation - If not, documentation from the institution is required to confirm the appointment will be held by the activation date - The program is open to scientists proposing extraordinarily novel, creative, and technically sophisticated research plans - Projects must generate proof-of-principle for a novel technology platform relevant to cancer immunotherapy --- ## Application Process 1. **Letter of Intent (LOI):** - Submit electronically via the [CRI Application Portal](https://cri.us-1.smartsimple.com/) - Required documents (PDFs, uploaded individually): - Initial research concept (max 3 pages): includes aims, timelines, and transformative potential - Brief description of current research - Curriculum vitae and bibliography (limit bibliography to past 5 years or relevant publications) - CVs for group members (if applicable) and their research focus - Incomplete or over-length applications will be disqualified 2. **Full Application:** - By invitation only, following LOI review - Deadline typically in early March 3. **Award Activation:** - Earliest activation date is July 1 of the award year; awards activate on the first of the month - All documents must be single-spaced, 12-point font or larger - Only PDF files accepted - Adherence to [CRI award terms](https://www.cancerresearch.org/wp-content/uploads/2022/10/TECH_Terms_2022-10_-_web.pdf) is required --- ## Additional Information - No funds are provided for indirect costs - Projects meeting 12- and 24-month milestones may be eligible for follow-on funding - Policies and terms are non-negotiable and set by the CRI Board of Trustees - The most competitive proposals address areas where technological innovation is likely to have the greatest impact for cancer patients --- ## External Links - [Program Page: CRI Technology Impact Award](https://www.cancerresearch.org/technology-impact-award) - [CRI Application Portal](https://cri.us-1.smartsimple.com/) - [Terms and Conditions (PDF)](https://www.cancerresearch.org/wp-content/uploads/2022/10/TECH_Terms_2022-10_-_web.pdf) - [FAQ (PDF)](https://www.cancerresearch.org/wp-content/uploads/2024/09/Fellowship-FAQ_v6.pdf) - [General Grants Information](https://www.cancerresearch.org/apply-for-grants) --- ## Contact Information | Type | Details | |---------------|------------------------------------------------------------------------| | Email | grants@cancerresearch.org | | Phone | (800) 992-2623 | | Address | Cancer Research Institute, 29 Broadway, Floor 4, New York, NY 10006-3111 | | Contact Page | [Contact CRI](https://www.cancerresearch.org/contact) |

CRI Technology Impact Award

Sign in to see full grant listing